Walmark`s Total Asset Growth reached 11.3 % in 2017. This is 370 % less than in the previous year.
Buy annual subscriptions for all our products.
Company | Unit | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
Amgen Czech Republic | % | ... | ... | ... | ... | ... | 36.5 | 14.1 | -15.6 | 22.4 | 3.28 | |||||||
Bayer Czech Republic | % | ... | ... | ... | -41.7 | -26.0 | 22.0 | -2.28 | 21.7 | |||||||||
GlaxoSmithKline Czech Republic | % | ... | ... | ... | 15.9 | -23.6 | -1.81 | -15.0 | 4.34 | |||||||||
Merck Czech Republic | % | ... | ... | 25.8 | 12.5 | 8.86 | -12.5 | 11.3 | ||||||||||
Novartis Czech Republic | % | 12.2 | 8.05 | -0.432 | 9.23 | 16.1 | ||||||||||||
Pfizer Czech Republic | % | ... | ... | -3.91 | -12.3 | 11.1 | 3.91 | -33.7 | ||||||||||
Roche Czech Republic | % | ... | ... | ... | -9.52 | 4.74 | -4.23 | 3.23 | 9.98 | ... | ||||||||
Sanofi-Aventis Czech Republic | % | ... | ... | ... | ... | 1.84 | 4.11 | -18.3 | -12.8 | 12.2 | ||||||||
Servier Czech Republic | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 15.0 | 129 | 13.3 | ||
Walmark | % | ... | ... | ... | -2.00 | -7.16 | 23.1 | 6.71 | -23.3 |